April 4, 2011
CARLSBAD, Calif. - Life Technologies Corporation (NASDAQ: LIFE) today announced the launch of its TaqMan® Mutation Detection Assays -- highly sensitive and novel molecular analysis research tools with the precision to detect a single mutant molecule hiding in a background of 1 million normal copies. Developed for clinical researchers to validate and screen for extremely [...]
April 4, 2011
SANTA CLARA, Calif. - Agilent Technologies Inc. (NYSE: A) today announced that major genomics research center BGI has achieved Certified Service Provider (CSP) status for the Agilent SureSelect XT Target Enrichment System for next-generation sequencing. The Agilent CSP Program is a partnership program for service providers wishing to provide a higher level of data quality [...]
Caliper Life Sciences Launches Novel COX-2 Probe to Enable Personalized Medicine Research
April 4, 2011
Oncology - HOPKINTON, Mass. - Caliper Life Sciences, Inc. (NASDAQ: CALP), a leading provider of tools and services for drug discovery, life sciences research and molecular diagnostics, today announced the launch of XenoLight(TM) RediJect(TM) COX-2 Probe (Fluorocoxibs), a novel fluorescent imaging agent for pre-clinical research that specifically detects the cyclooxygenase-2 (COX-2) biomarker noninvasively in live [...]
Block Engineering Announces Major Equity Investment
April 4, 2011
Marlborough, MA - Block Engineering, a leading developer of Quantum Cascade Laser (QCL) based spectrometers, announced today that Michael L. Bickford, of Vero Beach, Florida, has made a major equity investment and has become a Director. Daniel J. Cavicchio, Jr., Executive Chairman, said: "I am very pleased that Michael has decided to join our company. [...]
Affymetrix’ Second Generation OncoScan(TM) FFPE Express Enhanced by Cancer Researchers
April 4, 2011
Santa Clara, CA - Affymetrix, Inc. (NASDAQ: AFFX) today announced at the American Association for Cancer Research (AACR) 102nd Annual Meeting 2011 in Orlando, Florida, the launch of its second-generation OncoScan™ FFPE Express platform (formerly MIP Copy Number Service). OncoScan™ FFPE Express 2.0offers enhanced coverage of tumor suppressors and oncogenes and provides the same proven [...]
Thermo Fisher Scientific Completes Sales of Athena Diagnostics and Lancaster Laboratories
April 4, 2011
WALTHAM, Mass. - Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, has completed the previously announced sales of its two laboratory-testing services businesses, Athena Diagnostics and Lancaster Laboratories, in two separate transactions, resulting in total proceeds of $940 million. Athena Diagnostics has been sold to Quest Diagnostics for $740 million. Based [...]
April 4, 2011
SANTA CLARA, Calif. - Agilent Technologies, Inc. (NYSE: A) today introduced the Agilent SureCycler 8800, a full-featured thermal cycler that eliminates the need to choose between popular features of other major PCR instruments. The SureCycler 8800 expands Agilent's portfolio of PCR solutions, including a full selection of enzymes, RT-PCR kits and mutagenesis kits. The Agilent [...]
Bruker Announces Closing of Michrom Acquisition
April 4, 2011
FREMONT, Calif. - Bruker today announced the closing of its acquisition of Michrom Bioresources, Inc. (Michrom), a 20 year old, privately owned company located in Auburn, California, after receiving unanimous Michrom shareholder approval. The acquisition is not expected to have a material effect on Bruker's 2011 financials. All former Michrom employees have been offered employment [...]
April 4, 2011
Sunnyvale, Calif. - Picarro, the maker of the world’s leading instruments for carbon and water cycle measurements today unveiled its new Induction Module - Cavity Ring-Down Spectroscopy (IM-CRDS) system, a compact, field-deployable and high-precision water isotope measurement solution that can extract water from plant, soil, and food samples and measure hydrogen and oxygen isotopes in [...]
Thermo Fisher Scientific Extends Cash Tender Offer for Dionex Corporation
April 4, 2011
WALTHAM, Mass. - Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its previously announced tender offer to acquire all of the outstanding shares of Dionex Corporation (NASDAQ: DNEX) for $118.50 per share in cash has been extended and will now expire at 7:00 p.m., New York City time, [...]

